1-2 of 2
Diana Griffith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Therapy In Mast Cell Neoplasms: Co-Targeting KIT and NFAT Signaling Pathways

Alison Macleod, Janice Patterson, Carol Beadling, PhD, Diana Griffith, Ajia Town, Arin McKinley, Michael C. Heinrich, MD
Journal: Blood
Blood (2013) 122 (21): 4105.
https://doi.org/10.1182/blood.V122.21.4105.4105
Published: 2013
Journal Articles

Dasatinib (BMS-354825), a Multi-Targeted Kinase Inhibitor, Inhibits the Kinase Activity of Wild-Type, Juxtamembrane and Activation Loop Mutant Kit Isoforms Associated with Human Malignancies.

Marcus M. Schittenhelm, MD, Sharon Shiraga, Arin Schroeder, Amie S. Corbin, Diana Griffith, Francis Y. Lee, PhD, Michael W. Deininger, MD, PhD, Brian J. Druker, MD, Michael C. Heinrich, MD
Journal: Blood
Blood (2005) 106 (11): 3358.
https://doi.org/10.1182/blood.V106.11.3358.3358
Published: 2005